Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 14, 2020	5	Annual filing director officer or owner of more than ten percent.	0000899243-20-004675.pdf 0000899243-20-004675.rtf View HTML
April 28, 2023	ARS	An annual report to security holders	0001193125-23-125003.pdf 0001193125-23-125003.rtf View HTML
April 25, 2024	ARS	An annual report to security holders	0001517022-24-000047.pdf 0001517022-24-000047.rtf View HTML
October 13, 2015	SC 13G/A	An amendment to the SC 13G filing	0000790502-15-000055.pdf 0000790502-15-000055.rtf View HTML
January 25, 2016	SC 13G/A	An amendment to the SC 13G filing	0000790502-16-000061.pdf 0000790502-16-000061.rtf View HTML
February 12, 2016	SC 13G/A	An amendment to the SC 13G filing	0000897069-16-000698.pdf 0000897069-16-000698.rtf 0000897069-16-000698.xls View HTML
February 12, 2016	SC 13G/A	An amendment to the SC 13G filing	0001193125-16-461770.pdf 0001193125-16-461770.rtf 0001193125-16-461770.xls View HTML
January 19, 2017	SC 13G/A	An amendment to the SC 13G filing	0000215457-17-001222.pdf 0000215457-17-001222.rtf View HTML
February 13, 2017	SC 13G/A	An amendment to the SC 13G filing	0001193125-17-039994.pdf 0001193125-17-039994.rtf 0001193125-17-039994.xls View HTML
February 14, 2017	SC 13G/A	An amendment to the SC 13G filing	0000315066-17-001401.pdf 0000315066-17-001401.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax